Michael Bristow, MD, Cardiology, Denver, CO

MichaelR.BristowMD

Cardiology Denver, CO

Adult Congenital Heart Disease, Interventional Cardiology

Professor, Medicine, University of Colorado School of Medicine

Are you Dr. Bristow?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 51 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Michael Bristow, MD is a cardiologist in Denver, Colorado. He is currently licensed to practice medicine in Colorado, Utah, and California. He is a Professor at University of Colorado School of Medicine.

Education & Training

  • Stanford University
    Stanford UniversityFELLOWSHIP
  • Stanford University
    Stanford UniversityRESIDENCY
  • Stanford University
    Stanford UniversityINTERNSHIP
  • University of Illinois College of Medicine
    University of Illinois College of MedicineMEDICAL_SCHOOL

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 1991 - 2021
  • UT State Medical License
    UT State Medical License 1984 - 1992
  • CA State Medical License
    CA State Medical License 1973 - Present
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1985
  • Fellow (FACC) American College of Cardiology

Clinical Trials

Publications & Presentations

PubMed

Authored Content

  • Dynamic Regulation of SARS-CoV-2 Binding and Cell Entry Mechanisms in Remodeled Human Ventricular MyocardiumJune 2020

Press Mentions

  • Anne Prener, M.D., Ph.D. Appointed to Renovacor Board of Directors and Scientific Advisory Board
    Anne Prener, M.D., Ph.D. Appointed to Renovacor Board of Directors and Scientific Advisory BoardFebruary 24, 2020
  • Cover Story | What's Your Path?
    Cover Story | What's Your Path?September 20, 2019
  • Dose Response of Beta-Blockers in Adrenergic Receptor Polymorphism Genotypes Paper Published in Circulation: Genomic and Precision Medicine
    Dose Response of Beta-Blockers in Adrenergic Receptor Polymorphism Genotypes Paper Published in Circulation: Genomic and Precision MedicineMarch 06, 2019
  • Join now to see all

Grant Support

  • Beta-Blocker Effect On Remodeling And Gene ExpressionNational Center For Research Resources2004–2008
  • Genetic-Adrenergic Interactions In Myocardial FailureNational Heart, Lung, And Blood Institute2004–2007
  • Dynamic Expression Profiling In The Intact Human HeartNational Heart, Lung, And Blood Institute2002–2003
  • Altered Gene Expression In The Failing Human HeartNational Heart, Lung, And Blood Institute1999–2003
  • Effects Of Chronic Trtmnt WI Bucindolol HCL Or Metoprolol TartrateNational Center For Research Resources1999–2002
  • Contractile Protein Expression In Failing Human HeartNational Heart, Lung, And Blood Institute1998–2002
  • Beta Adrenergic Blockade In Patients With Congestive Heart FailureNational Center For Research Resources1996–2002
  • Parallel, Dose RESP Study--Sustnd Released Moxonidine In CHF PatientsNational Center For Research Resources1999–2000
  • Efficacy Of IV Milrinone In Patients With Congestive Heart FailureNational Center For Research Resources1998–2000
  • Postgraduate Training In Cardiovascular ResearchNational Heart, Lung, And Blood Institute1996–2000
  • Adrenergic Mechanisms In The Intact Failing Human HeartNational Heart, Lung, And Blood Institute1993–1996
  • Therapy With And Withdrawal Of Beta Adrenergic Blockade In PT W Conge Heart FailNational Center For Research Resources1995
  • OPC 18790 In Subjects With Heart FailureNational Center For Research Resources1993–1995
  • A Dose Range Finding Study Of Intravenous 349u85 HCL In Congestive Heart FailureNational Center For Research Resources1993–1995

Professional Memberships